Christopher J. Coughlin

About Christopher

Christopher J. Coughlin has been a director of Alexion since July 2014. He served as Advisor to the Chairman and CEO of Tyco International Ltd., a global provider of diversified products, services and industries, from 2010 to 2012, and as Executive Vice President and Chief Financial Officer of Tyco from 2005 to 2010 and during a period of significant international growth and restructuring. Mr. Coughlin previously served at the Interpublic Group of Companies, Inc. as Executive Vice President, Chief Operating Officer from 2003 to 2004. From 1998 to 2003, he served as Executive Vice President and Chief Financial Officer of Pharmacia Corporation. From 1997 to 1998 he was President, International at Nabisco Group Holdings and from 1996 to 1997 was Executive Vice President and Chief Financial Officer of Nabisco. From 1981 to 1996, Mr. Coughlin held various positions with Sterling Winthrop Incorporated, including Chief Financial Officer. Mr. Coughlin currently serves on the Board of Directors of Allergan plc. He previously served on the Board of Directors of Covidien (acquired by Medtronic), Actavis (which acquired Allergan), Dun & Bradstreet, Forest Laboratories (acquired by Actavis plc), Hologic, Inc., Dipexium Pharmaceuticals, Inc., The Interpublic Group of Companies, Monsanto Company, and Perrigo Company.

Mr. Coughlin received a bachelor’s degree in accounting from Boston College.

Mr. Coughlin is Chair of the Audit and Finance Committee and a member of the Leadership and Compensation Committee.

Donnan, diagnosed with aHUS at 39 years old, and his two children
I can chase my kids and play again. I think knowing what I have brings a peace to my life.”